I agree that this site is using cookies. You can find further informations here.
X
Dafni, U.
154  results:
Search for persons X
?
1

12P Atezolizumab plus bevacizumab and chemotherapy in EGFR-..:

Frueh, M. ; Soo, R.A. ; Vervita, A....
ESMO Open.  9 (2024)  - p. 102591 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in t..:

Martín-Lluesma, S. ; Svane, I.M. ; Dafni, U....
Annals of Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

120MO Adjuvant pembrolizumab versus placebo for early-stage..:

Besse, B. ; Havel, L. ; Peters, S....
Immuno-Oncology and Technology.  20 (2023)  - p. 100592 , 2023
Link: https://doi.org/10.1016/..
 
?
4

16MO Clinical impact of plasma EGFR analysis: Results from ..:

Soo, R.A. ; Dafni, U. ; Han, J-Y....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S49-S50 , 2023
Link: https://doi.org/10.1016/..
 
?
5

ESMO Guidance for Reporting Oncology real-World evidence (G..:

Castelo-Branco, L. ; Pellat, A. ; Martins-Branco, D....
ESMO Real World Data and Digital Oncology.  1 (2023)  - p. 100003 , 2023
Link: https://doi.org/10.1016/..
 
?
6

191P ROS1 fusions in resected stage I-III adenocarcinoma (A..:

Speel, E-J.M. ; Radonic, T. ; Dafni, U....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S144-S145 , 2023
Link: https://doi.org/10.1016/..
 
?
7

COVID-19 in cancer patients: update from the joint analysis..:

Martin, P. ; Tsourti, Z. ; Ribeiro, J....
ESMO Open.  8 (2023)  3 - p. 101566 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Off-label despite high-level evidence: a clinical practice ..:

Zarkavelis, G. ; Amylidi, A.L. ; Verbaanderd, C....
ESMO Open.  8 (2023)  1 - p. 100604 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Low neutralizing antibody titers after asymptomatic or non-..:

Lazor-Blanchet, C. ; Zygoura, P. ; Dafni, U....
Journal of Infection.  84 (2022)  5 - p. 722-746 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Impact of smoking status on the relative efficacy of the EG..:

Dafni, U. ; Soo, R.A. ; Peters, S....
ESMO Open.  7 (2022)  3 - p. 100507 , 2022
Link: https://doi.org/10.1016/..
 
?
11

237P Immune checkpoint inhibitor therapy and outcomes from ..:

Cortellini, A. ; Dettorre, G. ; Dafni, U....
Immuno-Oncology and Technology.  16 (2022)  - p. 100226 , 2022
Link: https://doi.org/10.1016/..
 
?
12

5P Tumor microenvironment cellular crosstalk predicts respo..:

Dangaj, D. ; Barras, D. ; Ghisoni, E....
Immuno-Oncology and Technology.  16 (2022)  - p. 100110 , 2022
Link: https://doi.org/10.1016/..
 
?
13

COVID-19 in patients with cancer: first report of the ESMO ..:

Castelo-Branco, L. ; Tsourti, Z. ; Gennatas, S....
ESMO Open.  7 (2022)  3 - p. 100499 , 2022
Link: https://doi.org/10.1016/..
 
?
14

11P Association of VISTA-expressing CD66b-positive neutroph..:

Homicsko, K. ; Zygoura, P. ; Tissot, S....
Immuno-Oncology and Technology.  16 (2022)  - p. 100116 , 2022
Link: https://doi.org/10.1016/..
 
?
15

"The first ones now, will later be last": understanding the..:

Cherny, N.I. ; Dafni, U. ; Pentheroudakis, G....
ESMO Open.  7 (2022)  2 - p. 100413 , 2022
Link: https://doi.org/10.1016/..
 
1-15